Canada hesitates to update guidance on AstraZeneca

  • Detail
Canada hesitates to update guidance on AstraZeneca-Oxford vaccine amid potential link to blood clots | CBC News - Today News Post News Today || Canada News |

This is an excerpt from Second Opinion, a weekly roundup of health and medical science news emailed to?subscribers every Saturday morningThe province reported 40 more COVID-19 deaths. If you haven’t subscribed yet, you can do that by clickingBeijing has distributed hundreds of millions of doses abroad while trying to promote doubt abou?herewhere an outbreak swelled to 339 cases i.

Scientists in Europe have reportedly found a link between the AstraZeneca-Oxford COVID-19 vaccine and extremely rare but potentially fatal blood clots, but?Canadian public health officials have so far provided no update on guidance for the shot.

News broke on Friday that researchers in Germany and Norway said they had?found a mechanism that could cause the AstraZeneca-Oxford vaccine to create the blood clots in very rare circumstances, in addition to identifying a possible treatment for it.

The finding?comes after the European Medicines Agency (EMA) investigated 25 cases of the rare blood clots out of about 20 million AstraZeneca shots given?and concluded on Thursday that the benefits from the vaccine far outweigh its possible risks, although a definitive link could not be ruled out.

Copyright © 2011 JIN SHI